Search of: "Adalimumab" - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 106 studies with search of:

"Adalimumab"

Hide studies that are not seeking new volunteers.

Display Options

1	Recruiting	Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: adalimumab; Biological: adalimumab

2	Completed	Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Biological: placebo; Biological: adalimumab

3	Completed	Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Interventions:	Drug: adalimumab; Drug: adalimumab; Drug: adalimumab

4	Completed	Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Interventions:	Drug: placebo for adalimumab; Drug: adalimumab; Drug: adalimumab

5	Active, not recruiting	Adalimumab in Adult Japanese Subjects With Psoriasis
		Condition:	Psoriasis
		Interventions:	Biological: adalimumab; Biological: adalimumab

6	Active, not recruiting	An Open-Label Study of Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Moderate to Severe Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: adalimumab

7	Completed	Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Interventions:	Drug: adalimumab; Drug: MTX; Drug: placebo adalimumab, placebo MTX

8	Active, not recruiting	Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: placebo; Biological: adalimumab

9	Active, not recruiting	A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriasis
		Condition:	Psoriasis
		Intervention:	Biological: Humira (adalimumab)

10	Active, not recruiting	Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
		Condition:	Arthritis, Juvenile Rheumatoid
		Interventions:	Drug: adalimumab; Drug: adalimumab + methotrexate

11	Active, not recruiting	Comparator With Adalimumab and MTX Versus MTX in Subjects With Early Rheumatoid Arthritis
		Condition:	Early Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Drug: methotrexate; Biological: adalimumab

12	Active, not recruiting	Efficacy, Safety, Immunogenicity and Effect on Immune Response of Adalimumab Following Subcutaneous Administration in Patients With Active RA Treated Concomitantly With MTX.
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Biological: adalimumab; Drug: placebo

13	Active, not recruiting	Long-Term Safety and Tolerability Study in Subjects With Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: adalimumab

14	Not yet recruiting	Adalimumab for Inflammatory Osteoarthritis
		Condition:	Osteoarthritis
		Interventions:	Drug: adalimumab; Drug: adalimumab

15	Completed	A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Biological: adalimumab; Biological: adalimumab; Biological: placebo

16	Completed	Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Biological: adalimumab

17	Recruiting	Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
		Condition:	Ulcerative Colitis
		Interventions:	Biological: adalimumab; Biological: adalimumab; Biological: placebo

18	Completed	A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: adalimumab; Biological: Placebo

19	Completed	Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
		Conditions:	Arthritis; Psoriatic
		Interventions:	Drug: adalimumab; Drug: placebo for adalimumab

20	Active, not recruiting	Remission in Subjects With Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: adalimumab; Biological: placebo

21	Recruiting	Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-Inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing
		Condition:	Rheumatoid Arthritis
		Interventions:	Drug: adalimumab; Drug: placebo

22	Completed	Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Interventions:	Drug: adalimumab; Drug: placebo for adalimumab

23	Completed	Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Interventions:	Drug: adalimumab; Drug: placebo for adalimumab

24	Completed	Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
		Conditions:	Arthritis; Psoriatic
		Interventions:	Drug: adalimumab; Drug: placebo for adalimumab

25	Recruiting	A Study to Determine the Optimal Protocol for Treatment Initiation With Methotrexate and Adalimumab Combination Therapy in Patients With Early Rheumatoid Arthritis - OPTIMA
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: Humira (adalimumab) + methotrexate; Biological: Placebo + methotrexate

26	Recruiting	A 5-Year Registry Study of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)
		Condition:	Crohn's Disease
		Intervention:	Drug: adalimumab

27	Active, not recruiting	Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
		Condition:	Ankylosing Spondylitis
		Interventions:	Biological: adalimumab (D2E7); Biological: placebo

28	Active, not recruiting	A Study to Assess the Safety and Efficacy of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: Placebo; Biological: Adalimumab 40 mg; Biological: Adalimumab 80 mg

29	Completed	Humira in Rheumatoid Arthritis - Do Bone Erosions Heal?
		Conditions:	Rheumatoid Arthritis; Arthritis; Joint Diseases
		Intervention:	Drug: Adalimumab (Humira)

30	Recruiting	Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Hands and/or Feet
		Condition:	Psoriasis
		Interventions:	Drug: Humira; Drug: placebo; Drug: Humira

31	Approved for marketing	Open Label Study to Assess Efficacy and Safety of the Fully Human Anti-TNF-Alpha Monoclonal Antibody Adalimumab
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

32	Completed	Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
		Condition:	Rheumatoid Arthritis
		Interventions:	Biological: adalimumab; Biological: placebo

33	Approved for marketing	Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

34	Recruiting	Open Label Study of Adalimumab in Subjects Who Have a Sub-Optimal Response to Systemic Therapy or Phototherapy
		Condition:	Psoriasis
		Intervention:	Biological: adalimumab

35	Enrolling by invitation	Long-Term Open-Label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative Colitis
		Condition:	Ulcerative Colitis
		Intervention:	Biological: adalimumab

36	Completed	A Long Term Roll-Over Study to Investigate the Efficacy and Safety of Adalimumab Given Long-Term to Patients With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Drug: adalimumab

37	Recruiting	Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806
		Condition:	Crohn's Disease
		Intervention:	Biological: Adalimumab

38	Active, not recruiting	Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
		Condition:	Ankylosing Spondylitis
		Interventions:	Biological: adalimumab (D2E7); Biological: placebo

39	Active, not recruiting	Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

40	Active, not recruiting	Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

41	Active, not recruiting	Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
		Condition:	Psoriasis
		Intervention:	Drug: adalimumab

42	Recruiting	A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
		Condition:	Ankylosing Spondylitis
		Intervention:	Biological: adalimumab

43	Active, not recruiting	Self-Injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: Adalimumab

44	Recruiting	Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
		Condition:	Juvenile Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

45	Enrolling by invitation	Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) in Subjects With Moderate to Severe Psoriasis and Insufficient Response to Classic Systemic Treatment
		Condition:	Chronic Plaque Psoriasis
		Interventions:	Biological: adalimumab; Biological: Calcipotriol + Betamethasone

46	Recruiting	Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
		Condition:	Ulcerative Colitis
		Interventions:	Biological: adalimumab; Biological: placebo

47	Active, not recruiting	A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's Disease
		Condition:	Crohn's Disease
		Interventions:	Biological: adalimumab; Biological: Placebo

48	Completed	A Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)
		Condition:	Crohn's Disease
		Intervention:	Biological: adalimumab

49	Completed	A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis
		Condition:	Rheumatoid Arthritis
		Intervention:	Biological: adalimumab

50	Terminated	Trial of Adalimumab in Progressive Sarcoidosis
		Condition:	Sarcoidosis
		Intervention:	Drug: Adalimumab

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options